# Reversible Systolic Anterior Motion in the Absence of Left Ventricular Hypertrophy Following Acute Myocardial Infarction: A Report of a Rare Case

**Authors:** Rima Chaddad, Maher Hakim, Virginie Carreira, Jacinthe Khater

PMC · DOI: 10.7759/cureus.102450 · Cureus · 2026-01-28

## TL;DR

A rare case of reversible heart valve motion after a heart attack is reported, showing it can happen without thickened heart walls.

## Contribution

This paper presents a rare case of reversible systolic anterior motion without left ventricular hypertrophy following a heart attack.

## Key findings

- SAM resolved completely after three weeks with no heart wall thickening.
- Apical dysfunction and basal hyperkinesis likely caused the SAM in this case.
- No structural heart disease was found to explain the valve motion.

## Abstract

Systolic anterior motion (SAM) of the mitral valve is classically associated with hypertrophic cardiomyopathy (HCM); however, it may rarely occur in the absence of left ventricular hypertrophy (LVH), particularly in the setting of acute myocardial ischemia. This phenomenon remains poorly understood and poses diagnostic and therapeutic challenges.

We report the case of a 54-year-old woman presenting with non-ST-elevation myocardial infarction (NSTEMI). Transthoracic echocardiography showed a non-dilated left ventricle (LV end-diastolic diameter 45 mm), preserved systolic function (left ventricular ejection fraction (LVEF) 63%; end-diastolic volume 115 mL, end-systolic volume 42 mL), apical akinesia, and compensatory basal hyperkinesis. There was no LV hypertrophy (interventricular septum 8 mm; lateral wall 7 mm). SAM of the mitral valve was present, resulting in moderate mitral regurgitation and a dynamic left ventricular outflow tract (LVOT) gradient of 30 mmHg. The right ventricle was normal in size and function.

Cardiac magnetic resonance imaging demonstrated apical myocardial edema on T2-weighted sequences and a punctiform transmural late gadolinium enhancement in the inferomedial segment on phase-sensitive inversion recovery (PSIR) sequences, with no evidence of cardiomyopathy or structural substrate that could explain LVOT obstruction. Coronary angiography revealed a significant mid-left anterior descending artery lesion, successfully treated with drug-eluting stent implantation. Medical management included beta-blocker therapy and careful volume optimization, with avoidance of inotropes. Follow-up transesophageal echocardiography at three weeks confirmed complete resolution of SAM, mitral regurgitation, LVOT gradient, and apical wall-motion abnormalities. This case illustrates a rare, ischemia-induced and reversible form of SAM without LVH. LVH was excluded based on echocardiographic wall thickness measurements below established thresholds (interventricular septum 8 mm and lateral wall 7 mm), well under the diagnostic cutoff for LVH (>11 mm), likely mediated by transient apical dysfunction and basal hyperkinesis, altering ventricular geometry and flow dynamics.

## Linked entities

- **Diseases:** myocardial infarction (MONDO:0005068), hypertrophic cardiomyopathy (MONDO:0005045)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** ischemic SAM (MESH:D018917), hypertension (MESH:D006973), LVH (MESH:D017379), akinetic (MESH:D018476), Takotsubo (MESH:D054549), Acute Myocardial Infarction (MESH:D009203), infections (MESH:D007239), LV hypertrophy (MESH:D006984), myocardial ischemia (MESH:D017202), dehydration (MESH:D003681), acute infarction (MESH:D056989), cardiac murmur (MESH:D006337), heart failure (MESH:D006333), infarct (MESH:D007238), subaortic obstruction (MESH:D011662), anterior MI (MESH:D056988), HCM (MESH:D002312), coronary artery disease (MESH:D003324), akinesia (MESH:C537921), heart disease (MESH:D006331), tissue injury (MESH:D017695), mitral apparatus abnormalities (MESH:D007766), systole (MESH:D000092244), fibrosis (MESH:D005355), pain (MESH:D010146), dyslipidemia (MESH:D050171), LVOT obstruction (MESH:D000092242), acute coronary syndromes (MESH:D054058), coronary lesion (MESH:D003327), SAM (MESH:D009041), cardiogenic shock (MESH:D012770), papillary rupture (MESH:D012421), ischemic (MESH:D002545), NSTEMI (MESH:D000072658), myocardial edema (MESH:D004487), arrhythmias (MESH:D001145), STEMI (MESH:D000072657), LAD (MESH:D020759), chest pain (MESH:D002637), cardiomyopathy (MESH:D009202), ischemia (MESH:D007511), acute (MESH:D000208), fever (MESH:D005334), hyperkinesia (MESH:D006948), MR (MESH:D008944)
- **Chemicals:** antiplatelet (-), bisoprolol (MESH:D017298), atorvastatin (MESH:D000069059), dobutamine (MESH:D004280), ticagrelor (MESH:D000077486), alimemazine (MESH:D014291), ramipril (MESH:D017257), amitriptyline (MESH:D000639), lipid (MESH:D008055), alcohol (MESH:D000438), nitrates (MESH:D009566), oxygen (MESH:D010100), aripiprazole (MESH:D000068180), nicardipine (MESH:D009529), venlafaxine (MESH:D000069470), aspirin (MESH:D001241)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12947953/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12947953/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12947953/full.md

---
Source: https://tomesphere.com/paper/PMC12947953